Monopar Therapeutics (MNPR) stock is trading at $68.62, up 3.62% on the day. The current price is positioned below its key moving averages, indicating ongoing weakness ...
Monopar Therapeutics Inc. (MNPR) dropped 5.25% after the company announced its upcoming presentation at The Liver Meeting 2026, where new Phase 3 FoCus baseline and safety data will be shared. The ...
Monopar Therapeutics (MNPR) stock is trading at $71.315, down 3.93% for the session. The price sits below its key moving averages, and daily action is showing limited ...
Monopar Therapeutics (MNPR) stock is trading at $73.74, up 3.05% today. The price is positioned above its key short-term moving averages and remains beneath medium- and ...
Monopar Therapeutics (MNPR) stock is trading at $71.92, up 3.59% for the day. The price sits above its short-term averages but remains below key medium- and long-term ...
Monopar Therapeutics (MNPR) stock is trading at $69.37, down 3.39% on the day and holding near session lows. The stock is currently below its key moving ...
Monopar Therapeutics (MNPR) stock is trading at $72.38, down 6.06% on the day. The price currently sits below its key moving averages, reflecting continued pressure from ...
Monopar Therapeutics (MNPR) stock is trading at $80.3 after a decline of 4.38% today. The price sits below its key short-term average, but remains above primary medium- ...
Monopar Therapeutics (MNPR) stock is trading at $83.64, rising 4.77% on the day and closing near the session’s high. The price remains above its key moving averages, ...
Monopar Therapeutics (MNPR) stock is trading at $82.09, up 4.64% for the day. The price is currently positioned above its key short- and long-term moving ...
Monopar Therapeutics Inc. (MNPR) stock is trading at $80, down 4.54% on the day. The price sits below its key moving averages for the short and medium term, indicating ...
Monopar Therapeutics (MNPR) stock is trading at $86.35, down 3% on the day. The price sits below its short- and medium-term moving averages but continues to hold above ...
Monopar Therapeutics Inc. (MNPR) slumped 7.26% as continued weak momentum and firm selling pressure drove the latest move lower. The decline is supported by the stock trading beneath its 20-day ...
Monopar Therapeutics (MNPR) stock is trading at $90.91 after a daily decline of 5.91%. The move places the stock below its key short- and medium-term moving averages but ...
Monopar Therapeutics Inc. (MNPR) declined 4.93% today as sustained selling pressure and negative momentum continued to dominate short-term trading. The move is supported by the stock's weakness ...
Monopar Therapeutics (MNPR) stock is trading at $97.14, registering a sharp daily decline of 5.27%. The price currently sits below its short- and medium-term moving ...
Monopar Therapeutics (MNPR) stock is trading at $104.47, marking a daily drop of 3.38%. The price sits below its short- and medium-term moving averages but remains ...
Monopar Therapeutics (MNPR) stock is trading at $115.47, up 3.16% on the day and holding above its key moving averages. The price remains well supported relative to ...
Monopar Therapeutics Inc. (MNPR) fell 3.04% amid renewed technical selling pressure, with price action reflecting clear intraday weakness. The latest move is limited by mixed momentum signals and ...
Monopar Therapeutics (MNPR) stock is trading at $110.25, marking a daily decline of 3.15%. The price is positioned below its key short- and medium-term moving averages, ...
Monopar Therapeutics (MNPR) stock is trading at $114.33, up 3.17% on the day and closing near the session’s high. The move lifts the stock above its key moving ...